Intelligent Bio Solutions Inc [NASDAQ: INBS] closed the trading session at $5.95. The company report on February 2, 2024 at 8:30 AM that Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results.
– Year-over-year unaudited revenue increased 114% for the fiscal second quarter and 337% for the six months ended December 31, 2023 -.
The stocks have a year to date performance of 46.74 percent and weekly performance of 126.41 percent. The stock has been moved at -71.67 percent over the last six months. The stock has performed 57.96 percent around the most recent 30 days and changed 106.60 percent over the most recent 3-months.
If compared to the average trading volume of 702.84K shares, INBS reached to a volume of 93991620 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Intelligent Bio Solutions Inc [INBS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INBS shares is $156.60 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INBS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Intelligent Bio Solutions Inc is set at 0.86, with the Price to Sales ratio for INBS stock in the period of the last 12 months amounting to 4.32. The Price to Book ratio for the last quarter was 10.23, with the Price to Cash per share for the same quarter was set at 0.13.
INBS stock trade performance evaluation
Intelligent Bio Solutions Inc [INBS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 126.41. With this latest performance, INBS shares gained by 57.96% in over the last four-week period, additionally sinking by -71.67% over the last 6 months – not to mention a drop of -96.80% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INBS stock in for the last two-week period is set at 68.15, with the RSI for the last a single of trading hit 74.25, and the three-weeks RSI is set at 62.52 for Intelligent Bio Solutions Inc [INBS]. The present Moving Average for the last 50 days of trading for this stock 3.64, while it was recorded at 3.35 for the last single week of trading, and 17.58 for the last 200 days.
Intelligent Bio Solutions Inc [INBS]: An insightful look at the core fundamentals
Intelligent Bio Solutions Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.25 and a Current Ratio set at 0.39.
Earnings per share (EPS) analysis for Intelligent Bio Solutions Inc [INBS] stock
With the latest financial reports released by the company, Intelligent Bio Solutions Inc posted -33.6/share EPS, while the average EPS was predicted by analysts to be reported at -43.2/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 22.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INBS.
Intelligent Bio Solutions Inc [INBS]: Institutional Ownership
The top three institutional holders of INBS stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in INBS stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in INBS stock with ownership which is approximately 5.8325%.
